Cargando…
Variation in complement protein C1q is not a major contributor to cognitive impairment in Parkinson’s disease
Traditional dogma regarding the brain as an immune exempt organ has changed in recent years. New research has highlighted the role of the classical complement cascade in both synaptic elimination and function, driven largely by the role of the pathway initiating protein C1q. Given the links between...
Autores principales: | Carbutt, Sophia, Duff, Jennifer, Yarnall, Alison, Burn, David J., Hudson, Gavin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Scientific Publishers Ireland
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407898/ https://www.ncbi.nlm.nih.gov/pubmed/25817358 http://dx.doi.org/10.1016/j.neulet.2015.03.048 |
Ejemplares similares
-
metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017) -
Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease
por: Pyle, Angela, et al.
Publicado: (2016) -
Cognitive impairment in Parkinson's disease: impact on quality of life of carers
por: Lawson, RA, et al.
Publicado: (2016) -
Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease
por: Dissanayaka, Nadeeka N.W., et al.
Publicado: (2017) -
Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)